The extraordinary general meeting of
Approval of the resolution of the board of directors of a managed share issue
The Extraordinary General Meeting unanimously decided, in accordance with the Board’s proposal, to approve the Board’s decision to issue a maximum number of 1,250,000 shares with derogation from the preferential right of shareholders at the subscription price of
The reason for waiving the shareholders’ pre-emptive right is to enable the Company to raise capital quickly and efficiently, which in turn provides flexibility for potential short-term investment opportunities, helps reduce exposure to price fluctuations on the capital market as well as the opportunity to benefit from the current interest in the Company’s shares from potential institutional investors. Additional reasons for the discrepancy are that it is seen as positive with increased participation in the Company among institutional investors. An overall assessment and a careful examination have been carried out by the Board of Directors, according to which an issue of new shares with derogation from the shareholders’ preferential right is a more justified alternative for the Company’s shareholders than a capital increase with subscription right and that it is objectively in the best interests of both the Company and its shareholders.
The subscription price has been determined through an accelerated order book process and the Board of Directors therefore believes that the subscription price correctly reflects current market conditions and demand.
By issuing shares, the share capital is increased by
For more details regarding the resolutions described above, please refer to the notice and full proposals available on the Company’s website, www.syntheticmr.com.
For more information, please contact:
+46 70 529 29 87
+46 70 619 21 00
(c) Decision 2022. All rights reserved., sources